Medtronic (MDT) Tops Q2 Estimates and Raises FY26 Outlook
Medtronic beat Q2 estimates with $9.0 billion in revenue and $1.36 EPS, lifting its full-year guidance.
BTC$62,291.00+3.20%
ETH$1,626.48+5.83%
USDT$0.9995+0.00%
USDC$0.9996+0.00%
XRP$1.14+5.57%
SOL$64.60+5.18%
TRX$0.3286+3.15%
FIGR_HELOC$1.03+0.46%
HYPE$58.79+0.64%
DOGE$0.0843+5.16%
USDS$0.9997+0.01%
LEO$9.55-0.31%
RAIN$0.0134+4.90%
XLM$0.2048+5.05%
ZEC$398.76+9.00%
BTC$62,291.00+3.20%
ETH$1,626.48+5.83%
USDT$0.9995+0.00%
USDC$0.9996+0.00%
XRP$1.14+5.57%
SOL$64.60+5.18%
TRX$0.3286+3.15%
FIGR_HELOC$1.03+0.46%
HYPE$58.79+0.64%
DOGE$0.0843+5.16%
USDS$0.9997+0.01%
LEO$9.55-0.31%
RAIN$0.0134+4.90%
XLM$0.2048+5.05%
ZEC$398.76+9.00%
This article provides a comprehensive overview of the latest earnings reports from Medtronic, Genuine Parts Company, and Krystal Biotech, highlighting key performance metrics and future guidance.
Medtronic beat Q2 estimates with $9.0 billion in revenue and $1.36 EPS, lifting its full-year guidance.
Medtronic's Q1 fiscal 2026 results surpassed expectations with an EPS of $1.26 and revenue of $8.6 billion.
Medtronic's fourth-quarter performance exceeded expectations, with notable growth in key segments.
Medtronic plc reported a revenue of $8.29 billion in the third quarter of fiscal year 2025, showing a 2.5% increase as reported and a 4.1% increase…
Medtronic plc (NYSE: MDT) reported a revenue of $8.4 billion for the second quarter of fiscal year 2025.
Medtronic plc (NYSE: MDT) reported a strong first quarter performance for fiscal year 2025, with a revenue of $7.915 billion.
Medtronic plc (NYSE: MDT) reported strong third-quarter fiscal year 2024 results, with revenue of $8.1 billion, surpassing expectations.